<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03806621</url>
  </required_header>
  <id_info>
    <org_study_id>2017033</org_study_id>
    <nct_id>NCT03806621</nct_id>
  </id_info>
  <brief_title>Rota China Registry</brief_title>
  <official_title>A Post-Approval Study of the RotablatorTM Rotational Atherectomy System in China</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beijing Anzhen Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Boston Scientific International Medical Trading (Shanghai) Co., Ltd.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Beijing Anzhen Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Rotational atherectomy (RA) facilitates percutaneous coronary intervention for complex de
      novo lesions with severe calcification. Some observational studies and a small randomized
      trial indicated that a strategy of routine RA did not conferred reduction in restenosis or
      MACE, but these studies are limited by missing follow-up, insufficient power to compare
      outcomes, and confounding factors in the RA group (long lesion length, etc.). With recent
      developments in medical therapy, advances in design and delivery of drug-eluting stents
      (DES), and advances in noninvasive and intravascular coronary imaging, the use of RA in
      current real-world practice remains to be well determined. We aimed to compile real-world
      clinical outcomes data for the RotablatorTM Rotational Atherectomy System in routine clinical
      practice in China.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 19, 2018</start_date>
  <completion_date type="Anticipated">July 19, 2021</completion_date>
  <primary_completion_date type="Anticipated">August 19, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Major adverse cardiovascular event (MACE) (primary safety endpoint)</measure>
    <time_frame>30 days</time_frame>
    <description>The composite of any ischemia-driven target lesion revascularization (TLR), myocardial infarction (MI), or cardiac death. Periprocedural myocardial infarction, defined as in patients with normal baseline CK-MB, the peak CK-MB measured within 48 hours of the procedure rises to ≥ 10 x the local laboratory ULN, or to ≥ 5 x ULN with new pathologic Q-waves in ≥ 2 contiguous leads or new persistent LBBB (according to SCAI definition. J Am Coll Cardiol 2013;62:1563-70)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Procedural success rate (primary efficacy endpoint)</measure>
    <time_frame>Peri-procedural</time_frame>
    <description>A mean lesion diameter stenosis &lt;30% in 2 near-orthogonal projections with TIMI 3 flow, as visually assessed by the physician, without the occurrence of in-hospital MI, target vessel revascularization (TVR), or cardiac death</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>TLR rate</measure>
    <time_frame>At 30 days, 3, 6, and 12 months post-index procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Target lesion failure (TLF) rate</measure>
    <time_frame>At 30 days, 3, 6, and 12 months post-index procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>TVR rate</measure>
    <time_frame>At 30 days, 3, 6, and 12 months post-index procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Target vessel failure (TVF) rate</measure>
    <time_frame>At 30 days, 3, 6, and 12 months post-index procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MI rate</measure>
    <time_frame>At 30 days, 3, 6, and 12 months post-index procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiac death rate</measure>
    <time_frame>At 30 days, 3, 6, and 12 months post-index procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Non-cardiac death rate</measure>
    <time_frame>At 30 days, 3, 6, and 12 months post-index procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>All-cause death rate</measure>
    <time_frame>At 30 days, 3, 6, and 12 months post-index procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiac death or MI rate</measure>
    <time_frame>At 30 days, 3, 6, and 12 months post-index procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>All-cause death or MI rate</measure>
    <time_frame>At 30 days, 3, 6, and 12 months post-index procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>All-cause death, MI, or TVR rate</measure>
    <time_frame>At 30 days, 3, 6, and 12 months post-index procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stent thrombosis (ST) rate</measure>
    <time_frame>At 30 days, 3, 6, and 12 months post-index procedure</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Rate of arterial perforation (rotational atherectomy related or non-related)</measure>
    <time_frame>Peri-procedural</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Rate of abrupt coronary occlusion (including dissection and thrombosis)</measure>
    <time_frame>Peri-procedural</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Rate of significant coronary dissection (NHLBI types C-F)</measure>
    <time_frame>Peri-procedural</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Rate of consistent no reflow</measure>
    <time_frame>Peri-procedural</time_frame>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Coronary Artery Disease</condition>
  <arm_group>
    <arm_group_label>Rotational Atherectomy</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Rotational Atherectomy</intervention_name>
    <description>Patients with severe calcified lesions will receive rotational atherectomy during index PCI</description>
    <arm_group_label>Rotational Atherectomy</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        This national, multi-center, prospective, observational study will enroll at least 1000
        subjects in about 18 to 20 sites in China. All subjects who are candidates for PCI, signed
        the informed consent form and eligible to receive the treatment using RotablatorTM
        Rotational Atherectomy System will be evaluated for enrollment in this study.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age ≥18 years old

          -  Subject who is clinically indicated for PCI/stenting

          -  Written informed consent

          -  Subject is willing to comply with all protocol-required follow-up evaluation

          -  Subject must meet one of following angiographic/procedural inclusion criteria:

               -  Target lesion is moderately to severely calcified by visual estimate

               -  Unsuccessful balloon dilatation of the target lesion

               -  Unsuccessful passage of device(s) (microcatheter, balloon, or stent) across the
                  target lesion

        Exclusion Criteria:

          -  Subject has clinical symptoms and/or electrocardiogram (ECG) changes consistent with
             acute MI within 2 weeks

          -  Subject has any of the following angiographic findings:

               -  Thrombus present in the target vessel (by visual estimate)

               -  Significant dissection present in the target vessel (NHLBI types C-F)

               -  Lesion angulation &gt; 60°(by visual estimate)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Shao-Ping Nie, MD, PhD</last_name>
    <phone>86-10-84005256</phone>
    <email>spnie@ccmu.edu.cn</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Xiao Wang, MD</last_name>
    <phone>86-10-84005255</phone>
    <email>spaceeye123@126.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Beijing Anzhen Hospital, Capital Medical University</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100029</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shao-Ping Nie, MD, PhD</last_name>
      <phone>86-10-84005256</phone>
      <email>spnie@ccmu.edu.cn</email>
    </contact>
    <investigator>
      <last_name>Shao-Ping Nie, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Beijing Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Fucheng Sun, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>China-Japan Friendship Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jingang Zheng, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Fuwai Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jue Chen, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Peking Union Medical College Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Zhujun Shen, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Guangdong General Hospital</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jianfang Luo, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Sun Yat-sen University</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Zhimin Du, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Fuwai Central China Cardiovascular Hospital</name>
      <address>
        <city>Zhengzhou</city>
        <state>Henan</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Yan Chen, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Zhengzhou University</name>
      <address>
        <city>Zhengzhou</city>
        <state>Henan</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Chunguang Qiu, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Union Hospital, Tongji Medical College, Huazhong University of Science and Technology</name>
      <address>
        <city>Wuhan</city>
        <state>Hubei</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Xiaobo Mao, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Nanjing First Hospital</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Fei Ye, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Qilu hospital, Shandong University</name>
      <address>
        <city>Jinan</city>
        <state>Shandong</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Beian You, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Xi'an Jiaotong University</name>
      <address>
        <city>Xi'an</city>
        <state>Shanxi</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Xiaojun Bai, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Xijing Hospital</name>
      <address>
        <city>Xi'an</city>
        <state>Shanxi</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Chengxiang Li, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>West China Hospital, Sichuan University</name>
      <address>
        <city>Chengdu</city>
        <state>Sichuan</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Li Zhang, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>The First People's Hospital of Yunnan Province</name>
      <address>
        <city>Kunming</city>
        <state>Yunnan</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Hong Zhang, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University</name>
      <address>
        <city>Hangzhou</city>
        <state>Zhejiang</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Binquan Zhou, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>February 2019</verification_date>
  <study_first_submitted>December 12, 2018</study_first_submitted>
  <study_first_submitted_qc>January 14, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">January 16, 2019</study_first_posted>
  <last_update_submitted>February 24, 2019</last_update_submitted>
  <last_update_submitted_qc>February 24, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">February 26, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Beijing Anzhen Hospital</investigator_affiliation>
    <investigator_full_name>Shao-Ping Nie</investigator_full_name>
    <investigator_title>Professor of Medicine, Director, Emergency &amp; Critical Care Center</investigator_title>
  </responsible_party>
  <keyword>coronary artery disease</keyword>
  <keyword>percutaneous coronary intervention</keyword>
  <keyword>rotational atherectomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

